6-138406045-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014320.3(HEBP2):āc.313A>Gā(p.Ile105Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014320.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEBP2 | NM_014320.3 | c.313A>G | p.Ile105Val | missense_variant | 3/4 | ENST00000607197.6 | NP_055135.1 | |
HEBP2 | NM_001326380.2 | c.346A>G | p.Ile116Val | missense_variant | 3/4 | NP_001313309.1 | ||
HEBP2 | NM_001326381.2 | c.301+12A>G | intron_variant | NP_001313310.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEBP2 | ENST00000607197.6 | c.313A>G | p.Ile105Val | missense_variant | 3/4 | 1 | NM_014320.3 | ENSP00000475750.1 | ||
HEBP2 | ENST00000448741.5 | c.334+12A>G | intron_variant | 5 | ENSP00000392101.1 | |||||
HEBP2 | ENST00000367697.7 | c.301+12A>G | intron_variant | 2 | ENSP00000356670.3 | |||||
HEBP2 | ENST00000453452.1 | n.61+12A>G | intron_variant | 3 | ENSP00000395958.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251478Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135916
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727224
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.313A>G (p.I105V) alteration is located in exon 3 (coding exon 3) of the HEBP2 gene. This alteration results from a A to G substitution at nucleotide position 313, causing the isoleucine (I) at amino acid position 105 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at